drugset / Trial / NCT00857285

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

NCT00857285 ↗

Phase 3 Completed 130 enrolled Daiichi Sankyo Daiichi Sankyo Taiwan Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of oral administration of olmesartan medoxomil compared to losartan in subjects with mild to moderate hypertension.

Timeline

Start
2002-05
Primary completion
2003-08
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified — Oral
Subject Olmesartan medoxomil Unknown — Oral